Patrick Soon - Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner at ImmunityBio, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Executive Chairman, Global Chief Scientific and Medical Officer, Director, 10%+ Owner
Stock Symbol
IBRX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Patrick Soon since 9/18/2023

Holdings reported by Patrick Soon for ImmunityBio, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 32.6M $164M $5.02 Sep 11, 2023 Indirect
Common Stock 29.5M $148M $5.02 Sep 11, 2023 Direct
Restricted Stock Units 343K $1.39M $4.04 Feb 22, 2024 Direct Common Stock
Stock Option (right to buy) 1.19M Feb 22, 2024 Direct Common Stock
Amended and Restated Convertible Promissory Note $0 Sep 11, 2023 Indirect Common Stock
Amended and Restated Promissory Note $380M Dec 29, 2023 Indirect Common Stock
Convertible Promissory Note $30M Dec 29, 2023 Indirect Common Stock
Second Amended and Restated Convertible Promissory Note $0 Sep 11, 2023 Indirect Common Stock

Transactions reported by Patrick Soon for ImmunityBio, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.